Range
- - -
Vol / Avg.
0K/307.7K
Div / Yield
-
52 Wk
2.15 - 6.29
Mkt Cap
74.2M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.48
Shares
25.1M
Outstanding
25.1M
Total Float
21.6M
load more
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.390-0.380 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
GLMDGalmed Pharmaceuticals1.35%74.2M

Galmed Pharmaceuticals Frequently Asked Questions

Q

How do I buy Galmed Pharmaceuticals (GLMD) stock?

A

You can purchase shares of Galmed Pharmaceuticals (NASDAQ: GLMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Galmed Pharmaceuticals's (GLMD) competitors?

A

There are no as such competitors for Galmed Pharmaceuticals.

Q

What is the target price for Galmed Pharmaceuticals (GLMD) stock?

A

The latest price target for Galmed Pharmaceuticals (NASDAQ: GLMD) was reported by Canaccord Genuity on May 17, 2021. The analyst firm set a price target for 21.00 expecting GLMD to rise to within 12 months (a possible 609.46% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Galmed Pharmaceuticals (GLMD)?

A

The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $2.96 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Galmed Pharmaceuticals (GLMD) pay a dividend?

A

There are no upcoming dividends for Galmed Pharmaceuticals.

Q

When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?

A
Galmed Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Galmed Pharmaceuticals (GLMD) going to split?

A

There is no upcoming split for Galmed Pharmaceuticals.

Q

What sector and industry does Galmed Pharmaceuticals (GLMD) operate in?

A

Galmed Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.